Medistim
Logotype for Medistim

Medistim (MEDI) investor relations material

Medistim Q1 2026 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Medistim
Q1 2026 earnings summary7 May, 2026

Executive summary

  • Achieved record quarterly revenue of MNOK 201.7, up 11.1% year-over-year, with strong currency-neutral growth of 18.5%.

  • Own product sales grew 28.8% currency-neutral, with all regions contributing; Americas up 30.9%, EMEA up 11.5%, APAC up 57.5%, and China sales up 74.6%.

  • EBIT margin was 28.3% (EBIT MNOK 57.1), slightly lower than last year due to U.S. tariffs and sales mix.

  • Dividend of NOK 8 per share (MNOK 146.2) approved.

  • Direct sales operation established in Japan to strengthen APAC presence and capture distributor margin.

Financial highlights

  • Revenue: MNOK 201.7 (Q1 2026), up 11.1% year-over-year; currency-neutral growth at 18.5%.

  • EBIT: MNOK 57.1 (Q1 2026), EBIT margin 28.3%; EBITDA: MNOK 63.3, slightly below last year.

  • Gross margin: 79.6% (Q1 2026), impacted by APAC growth and U.S. tariffs.

  • Profit after tax: MNOK 40.3; EPS: NOK 2.20.

  • Cash position strong at MNOK 209.8; equity ratio 74.3%.

Outlook and guidance

  • Strong growth expected in APAC, especially China and Japan, with direct sales model enhancing margins.

  • Americas and U.S. expected to remain primary growth drivers.

  • Focus on expanding direct market coverage, flexible pricing, and growing vascular surgery segment.

  • Gross margin on own products expected to improve as direct sales increase.

  • Ongoing investments in R&D and IT infrastructure to support innovation and future growth.

Quantify the ongoing impact of US tariffs
Expected margin uplift from Japan direct model
SMARTFLOW trial role in changing US guidelines
Japan direct sales transition: Q1 impact and outlook?
Gross margin decline: Impact of tariffs and APAC mix?
US market: Capital sales trend and pricing strategy
Japan direct sales and margin capture potential
SMARTFLOW trial and U.S. guideline inclusion
U.S. price increases vs volume growth trends
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
Research faster. Power your platform.

Next Medistim earnings date

Logotype for Medistim
Q2 202619 Aug, 2026
Medistim
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Medistim earnings date

Logotype for Medistim
Q2 202619 Aug, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Explore our global coverage